ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH ETANERCEPT-METHOTREXATE THERAPY IN SUBJECTS WITH MODERATELY ACTIVE RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM THE PRESERVE TRIAL

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
Freundlich, Bruce [3 ]
Pavelka, Karel [4 ,5 ]
Nash, Peter [6 ]
Miranda, Pedro [7 ,8 ]
Hammond, Constance [9 ]
Vlahos, Bonnie [9 ]
Pedersen, Ronald [9 ]
Koenig, Andrew S. [9 ]
机构：
[1] Med Univ Vienna, Div Rheumatol, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Univ Penn, Dept Rheumatol, Philadelphia, PA 19104 USA
[4] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic
[5] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic
[6] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
[7] Univ Chile, Dept Rheumatol, Santiago, Chile
[8] Hosp San Juan Dios, Santiago, Chile
[9] Pfizer Inc, Dept Specialty Care, Collegeville, PA USA
来源：
RHEUMATOLOGY | 2011年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：ii12 / ii12
页数：1
相关论文
共 50 条
  • [21] Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis
    Maynard, Carson
    Mikuls, Ted R.
    Cannon, Grant W.
    England, Bryant R.
    Conaghan, Philip G.
    Ostergaard, Mikkel
    Baker, Daniel G.
    Kerr, Gail
    George, Michael D.
    Barton, Jennifer L.
    Baker, Joshua F.
    ARTHRITIS CARE & RESEARCH, 2020, 72 (03) : 326 - 333
  • [22] PREDICTORS OF LOSS OF CLINICAL REMISSION WITH ETANERCEPT 50 MG, 25 MG OR PLACEBO COMBINED WITH METHOTREXATE IN MODERATE RHEUMATOID ARTHRITIS PATIENTS: RESULTS OF THE PRESERVE TRIAL
    Smolen, J. S.
    Szumski, A.
    Koenig, A. S.
    Jones, T. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 367 - 367
  • [23] One-Year Results from the Canadian Methotrexate and Etanercept Outcome (CAMEO) Study: A Randomized Trial of Etanercept and Methotrexate versus Etanercept Alone in Active Rheumatoid Arthritis
    Pope, Janet
    Haraoui, Boulos
    Thorne, Carter
    Poulin-Costello, Melanie
    Vieira, Andrew
    Keystone, Edward
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 998 - 999
  • [24] Maintenance of Remission After Withdrawal of Etanercept or Methotrexate in Patients with Rheumatoid Arthritis in Sustained Remission on Combination Therapy: Results from a Randomized, Double-blind, Controlled Trial
    Curtis, Jeffrey R.
    Emery, Paul
    Karis, Elaine
    Haraoui, Boulos
    Bykerk, Vivian
    Yen, Priscilla
    Kricorian, Gregory
    Chung, James
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Kricorian, Greg
    Karis, Elaine
    Rebello, Sabrina
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ACR OPEN RHEUMATOLOGY, 2020, 2 (10) : 588 - 594
  • [26] Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?
    Gualtierotti, Roberta
    Casella, Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (02) : 223 - 224
  • [27] Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?
    Roberta Gualtierotti
    Francesco Casella
    Internal and Emergency Medicine, 2014, 9 : 223 - 224
  • [28] Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
    Smolen, Josef S.
    Emery, Paul
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Pavelka, Karel
    Durez, Patrick
    Guerette, Benoit
    Kupper, Hartmut
    Redden, Laura
    Arora, Vipin
    Kavanaugh, Arthur
    LANCET, 2014, 383 (9914): : 321 - 332
  • [29] BASAL METABOLIC RATE AS AN INDICATOR OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND PREDICTOR OF REMISSION: AUSTRALIAN RESULTS FROM PERIOD 1 OF THE PRESERVE TRIAL
    Buchanan, R.
    Will, R.
    Koenig, A.
    Szumski, A.
    Jones, H.
    Thirunavukkarasu, K.
    Witcombe, D.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 15 - 15
  • [30] EFFECT OF WITHDRAWING ETANERCEPT OR METHOTREXATE ON PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION ON COMBINATION THERAPY: RESULTS FROM THE SEAM-RA TRIAL
    Curtis, J.
    Karis, E.
    Bykerk, V.
    Kricorian, G.
    Yen, P.
    Emery, P.
    Haraoui, P.
    Collier, D.
    Stolshek, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 66 - 66
12345